RxDoctor Payments Data

Erik Simon

Chicago, ILNPI 1093106700

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (49.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Biosense Webster, Inc. at 42.6% of the total. 2025 is the largest year on record at $23,213, more than ten times the $400 reported in 2021.

$35,829in general payments, 2019–2025

Across 161 payments — averaging $222.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biosense Webster, Inc.$15K
  • Boston Scientific$7K
  • Abbott$7K
  • Medtronic$5K
  • Biotronik Inc.$427
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$412
  • plus $1K from 15 others

What the payments were for

  • Consulting fees$9,00025%
  • Grants$17,54549%
  • Travel & lodging$2,2716%
  • Food & beverage$5,87916%
  • Education$1,1333%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →